Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00338 |
LRRC15 Protein, Human, Recombinant (His & Avi), Biotinylated
Leucine-rich repeat-containing |
Human | HEK293 Cells |
The type I transmembrane protein 15-leucine-rich repeat containing membrane protein (LRRC15) is a member of the LRR superfamily. The LRR family is a structural module for protein-protein and protein-matrix interactions used for molecular recognition process such as cell adhesion, signal transduction, DNA repair, and RNA processing. The LRRC15 is also a transmembrane protein demonstrated to play important roles in cancer. LRRC15 expression was notably increased 4.6-fold in cariesdiseased pulpal t... | |||
TMPK-00338 |
LRRC15 Protein, Human, Recombinant (His & Avi)
LRRC15,LIB |
Human | CHO Cells |
The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation. LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge of migrating cells, the expression of which in normal tissues is restricted to the invasive cytotrophoblast layer of the placenta; small interfering (siRNA)-mediated suppression of LRRC15 expression in breast cancer cells leads to abrogation of invasiveness in vitro. LRRC15 Prote... | |||
TMPY-06148 |
LRRC15 Protein, Human, Recombinant (His)
leucine rich repeat containing 15... |
Human | HEK293 Cells |
LRRC15 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 59.2 kDa and the accession number is Q8TF66-1. | |||
TMPK-01309 |
LRRC15 Protein, Canine, Recombinant (His)
LIB,LRRC15 |
Canine | HEK293 Cells |
The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation. LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge of migrating cells, the expression of which in normal tissues is restricted to the invasive cytotrophoblast layer of the placenta; small interfering (siRNA)-mediated suppression of LRRC15 expression in breast cancer cells leads to abrogation of invasiveness in vitro. LRRC15 Prote... |